Abstract
Acrosoxacin was given as a single 300 mg oral dose to 105 patients with acute gonorrhoea. Of the 100 patients followed completely there was a 93% cure rate and 33% of men developed postgonococcal urethritis (PGU). This compared with a 97% cure and 30% PGU with 2 megaunits penicillin. The in vitro activity of acrosoxacin in Nottingham against strains of Neisseria gonorrhoeae showed that it was a highly active agent with 90% of strains inhibited by a concentration of 0.03 mg/l.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- McCutchan J. A., Adler M. W., Berrie J. R. Penicillinase-producing Neisseria gonorrhoeae in Great Britain, 1977-81: alarming increase in incidence and recent development of endemic transmission. Br Med J (Clin Res Ed) 1982 Jul 31;285(6338):337–340. doi: 10.1136/bmj.285.6338.337. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Shahidullah M. Single-dose treatment of uncomplicated gonorrhoea in males with minocycline. Br J Vener Dis. 1975 Apr;51(2):97–98. doi: 10.1136/sti.51.2.97. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Warren C. A., Shannon K. P., Phillips I. In-vitro antigonococcal activity of rosoxacin (WIN 35213). Br J Vener Dis. 1981 Feb;57(1):33–35. doi: 10.1136/sti.57.1.33. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Young H. Cultural diagnosis of gonorrhoea with modified New York City (MNYC) medium. Br J Vener Dis. 1978 Feb;54(1):36–40. doi: 10.1136/sti.54.1.36. [DOI] [PMC free article] [PubMed] [Google Scholar]